{"id":"W2149546612","doi":"10.3324/haematol.2014.111245","title":"A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E","year":2014,"lang":"en","type":"letter","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal; Institute for Research in Immunology and Cancer; Jewish General Hospital","funders":"U.S. Public Health Service; National Institutes of Health; Université de Montréal; Jewish General Hospital; Centre National de la Recherche Scientifique; McGill University; Leukemia and Lymphoma Society","keywords":"Cytarabine; Medicine; Refractory (planetary science); Ribavirin; Myeloid leukemia; Internal medicine; Acute leukemia; Myeloid; Gastroenterology; Oncology; Pharmacology; Leukemia; Virology; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004518972,0.0005992518,0.002231525,0.0002567754,0.0001243305,0.00002138838,0.0002560418,0.0009546023,0.0000483124],"category_scores_gemma":[0.0003065637,0.0003017232,0.0002420812,0.0002285665,0.001015805,0.0000485026,0.00007112823,0.0009132058,0.000004122653],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003559672,"about_ca_system_score_gemma":0.0006499416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001110771,"about_ca_topic_score_gemma":0.000007022759,"domain_scores_codex":[0.9970466,0.0002494759,0.0008420584,0.0007378977,0.0005578679,0.0005660384],"domain_scores_gemma":[0.9956599,0.00214613,0.0007250219,0.001021113,0.0003048923,0.0001429223],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.4412763,0.002890685,0.0001336588,0.004000444,0.005936986,0.004415244,0.0009773517,0.000001687013,0.02188105,0.0001024032,0.5007424,0.01764177],"study_design_scores_gemma":[0.4026166,0.08129947,0.0001434852,0.0008645496,0.004087464,0.002067331,0.00009507796,0.0008041319,0.01570415,0.0001090141,0.4915768,0.0006319495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9078553,0.001594749,0.0001767484,0.0827881,0.0001179774,0.006929435,0.0002681479,0.00007090873,0.0001986363],"genre_scores_gemma":[0.8106253,0.03787195,0.008887674,0.1125736,0.004419226,0.006362102,0.004367559,0.000765514,0.01412711],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09723001,"threshold_uncertainty_score":0.9999435,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.036414860354982,"score_gpt":0.3185717545133223,"score_spread":0.2821568941583403,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}